- Home
- VNDA vs MUZE Comparison
VNDA vs MUZE Comparison
Compare VNDA & MUZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VNDA | MUZE |
|---|---|---|
| Founded | 2002 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.1M | 271.6M |
| IPO Year | 2005 | 2025 |
Fundamental Metrics
Financial Performance| Metric | VNDA | MUZE |
|---|---|---|
| Price | $4.04 | $10.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $11.75 | N/A |
| AVG Volume (30 Days) | ★ 841.3K | 51.8K |
| Earning Date | 10-28-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $216,105,000.00 | N/A |
| Revenue This Year | $15.16 | N/A |
| Revenue Next Year | $35.50 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.72 | N/A |
| 52 Week Low | $4.01 | $9.83 |
| 52 Week High | $9.91 | $10.04 |
Technical Indicators
Market Signals| Indicator | VNDA | MUZE |
|---|---|---|
| Relative Strength Index (RSI) | 22.64 | 55.83 |
| Support Level | N/A | $9.93 |
| Resistance Level | $5.37 | N/A |
| Average True Range (ATR) | 0.18 | 0.00 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 4.66 | 42.86 |
Price Performance
Historical ComparisonAbout VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.